American Society of Regional Anesthesia and Pain Medicine August 2016 - 36

PRO

Use of Ziconotide as First Line Intrathecal Therapy?
continued...

10. Allen JW, Horais KA, Tozier NA, et al. Time course and role of morphine dose
and concentration in intrathecal granuloma formation in dogs: a combined
magnetic resonance imaging and histopathology investigation. Anesthesiology.
2006;105:581-589.

16. Hunter, C. Diwan, S. Deer, T. Neuroaugmentation by stimulation vs. intrathecal
drug delivery. In: Intrathecal Pump Delivery for Pain and Spasticity. Vol. 2. Diwan
S, Buvanendran A, Deer T (eds.). Philadelphia, Pennsylvania: Elsevier 2012;129-
138.

11. Jourdain V, Cantin L, Prud'homme M, Fourneir-Grosselin M. Intrathecal morphine
therapy-related granuloma: faster to grow than thought. Neuromodulation.
2009;12:164-169.

17. Coffey RJ, Owens ML, Broste SK, et al. Mortality associated with implantation
and management of intrathecal opioid drug infusion systems to treat noncancer
pain. Anesthesiology. 2009;111(4):881-891.

12. Gofeld M, McQueen CK. Ultrasound-guided intrathecal pump access and
prevention of the pocket fill. Pain Med. 2011;12:607-611.

18. Hayek S, Hanes M, Wang C. Ziconotide combination intrathecal therapy for
noncancer pain is limited secondary to delayed adverse effects: a case series
with a 24-month follow-up. Neuromodulation. 2014;18:397-403.

13. Bowersox S, Gadbois T, Singh T, et al. Selective N-type neuronal voltagesensitive calcium channel blocker, SNX-111, produces spinal antinociception
in rat models of acute, persistent and neuropathic pain. J Pharmacol Exp Ther.
1996;279:1243-1249.
14. Deer TR, Prager J, Levy R, et al. Polyanalgesic Consensus Conference 2012:
Recommendations to reduce morbidity and mortality in intrathecal drug
delivery in the treatment of chronic pain. Neuromodulation. 2012;15:436-
464.
15. British Pain Society. Intrathecal drug delivery for the management of pain
and spasticity in adults: recommendations for best clinical practice, 2008.
Available at: http://www.britishpainsociety.org/. Accessed January 28,
2016.

36
2

19. Prialt. Contraindications. Available at http://www.prialt.com/hcp. Accessed Feb
15, 2016.
20. Phan SV, Waldfogel JM. Ziconotide-induced psychosis: a case report. Gen Hosp
Psychiatry. 2015;37:97.e11-12.
21. Hedden SL, Kennet J, Lipari R, et al. Behavioral health trends in the United
States: results from the 2014 National Survey on Drug Use and Health. Rockville,
Maryland: Substance Abuse and Mental Health Services Administration, Center
for Behavioral Health Statistics and Quality;2015.
22. National Institute on Drug Abuse (NIH). Overdose death rates. 2015. Available
at: http://www.drugabuse.gov/related-topics/trends-statistics/overdose-deathrates. Accessed November 23, 2015.

American Society of Regional Anesthesia and Pain Medicine
2016

http://www.prialt.com/hcp http://www.britishpainsociety.org/ http://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates http://use.gov/related-topics/trends-statistics/overdose-death-rates

Table of Contents for the Digital Edition of American Society of Regional Anesthesia and Pain Medicine August 2016